Margaret Kaczor
Stock Analyst
(n/a)
# 2,614
Out of 4,648 analysts
26
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Margaret Kaczor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STIM Neuronetics | Downgrades: Market Perform | n/a | $1.08 | - | 4 | Aug 12, 2024 | |
| CVRX CVRx, Inc. | Downgrades: Market Perform | n/a | $15.04 | - | 2 | May 1, 2024 | |
| CUTR Cutera | Upgrades: Market Perform | n/a | $0.55 | - | 3 | Mar 22, 2024 | |
| INGN Inogen | Upgrades: Outperform | n/a | $9.03 | - | 5 | Feb 15, 2024 | |
| SKIN The Beauty Health Company | Downgrades: Market Perform | n/a | $1.67 | - | 2 | Nov 14, 2023 | |
| STAA STAAR Surgical Company | Downgrades: Market Perform | n/a | $29.35 | - | 1 | Jun 7, 2023 | |
| NVRO Nevro | Downgrades: Market Perform | n/a | $5.39 | - | 2 | Aug 5, 2021 | |
| DVA DaVita | Downgrades: Market Perform | n/a | $145.12 | - | 2 | Sep 11, 2019 | |
| MDT Medtronic | Assumes: Market Perform | n/a | $89.47 | - | 1 | Jun 6, 2018 | |
| ABT Abbott Laboratories | Upgrades: Outperform | n/a | $117.60 | - | 3 | Jan 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $69.83 | - | 1 | Apr 27, 2017 |
Neuronetics
Aug 12, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.08
Upside: -
CVRx, Inc.
May 1, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $15.04
Upside: -
Cutera
Mar 22, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $0.55
Upside: -
Inogen
Feb 15, 2024
Upgrades: Outperform
Price Target: n/a
Current: $9.03
Upside: -
The Beauty Health Company
Nov 14, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.67
Upside: -
STAAR Surgical Company
Jun 7, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $29.35
Upside: -
Nevro
Aug 5, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $5.39
Upside: -
DaVita
Sep 11, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $145.12
Upside: -
Medtronic
Jun 6, 2018
Assumes: Market Perform
Price Target: n/a
Current: $89.47
Upside: -
Abbott Laboratories
Jan 25, 2018
Upgrades: Outperform
Price Target: n/a
Current: $117.60
Upside: -
Apr 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $69.83
Upside: -